Search Within

Billel Gasmi

Formats
  1. Meeting Abstract (10)
  2. Journal Article (8)
Groups
  1. Department of Medicine (18)
  2. GSK Faculty (17)
  3. Melanoma and Immunotherapeutics Service (17)
  4. Solid Tumor Oncology Division (17)
  5. Sloan Kettering Institute Postdocs (13)
  6. Biostatistics Service (9)

More Groups

People
  1. Taha Merghoub (17)
  2. Jedd Wolchok (16)
  3. Sadna Budhu (10)
  4. Cailian Liu (9)
  5. Roberta Zappasodi (9)
  6. Yanyun Li (9)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (1)
  4. 2018 (5)
  5. 2017 (2)
  6. 2016 (3)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (4)
  2. Cancer Research (3)
  3. Journal of Immunology (2)
  4. Oncotarget (2)
  5. Advances in Cancer Research (1)
  6. Blood (1)

More Publications

Publishers
  1. Biomed Central Ltd (4)
  2. American Association for Cancer Research (3)
  3. Cell Press (2)
  4. Impact Journals (2)
  5. The American Association of Immunologists, Inc (2)
  6. Academic Press, Elsevier Inc (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Opposing effects of CTLA-4 and PD-1 blockade on follicular helperlike T cells with immunosuppressive functions
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M.; Senbabaoglu, Y.; Gasmi, B.; Zhong, H.; Li, Y.; Liu, C.; Hirschhorhn-Cymerman, D.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies
    Journal Article

    Momtaz, P.; Pentsova, E.; Abdel-Wahab, O.; Diamond, E.; Hyman, D.; Merghoub, T.; You, D.; Gasmi, B.; Viale, A.; Chapman, P. B.
    Oncotarget (2016)

    Fulltext@MSK | Save
  • Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy
    Journal Article

    Holmgaard, R. B.; Brachfeld, A.; Gasmi, B.; Jones, D. R.; Mattar, M.; Doman, T.; Murphy, M.; Schaer, D.; Wolchok, J. D.; Merghoub, T.
    OncoImmunology (2016)

    Fulltext@MSK | Save
  • Presence of PD-1 expressing T cells predicts for inferior overall survival in newly diagnosed multiple myeloma
    Meeting Abstract

    Gasmi, B.; Smith, E. L.; Dogan, A.; Hsu, M.; Devlin, S.; Pichardo, J. D.; Chung, D. J.; Koehne, G.; Korde, N. S.; Landau, H. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The new era of cancer immunotherapy: Manipulating T-cell activity to overcome malignancy
    Journal Article

    Khalil, D. N.; Budhu, S.; Gasmi, B.; Zappasodi, R.; Hirschhorn-Cymerman, D.; Plitt, T.; De Henau, O.; Zamarin, D.; Holmgaard, R. B.; Murphy, J. T.; more...
    Advances in Cancer Research (2015)

    Fulltext@MSK | Save
  • Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Li, Y.; Gasmi, B.; Munn, D. H.; Allison, J. P.; Merghoub, T.; Wolchok, J. D.
    Cell Reports (2015)

    Fulltext@MSK | Save
  • Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
    Journal Article

    Rizvi, N. A.; Hellmann, M. D.; Snyder, A.; Kvistborg, P.; Makarov, V.; Havel, J. J.; Lee, W.; Yuan, J.; Wong, P.; Ho, T. S. ; more...
    Science (2015)

    Fulltext@MSK | Save